These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1035 related items for PubMed ID: 22535748

  • 1. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
    Jørgensen NB, Jacobsen SH, Dirksen C, Bojsen-Møller KN, Naver L, Hvolris L, Clausen TR, Wulff BS, Worm D, Lindqvist Hansen D, Madsbad S, Holst JJ.
    Am J Physiol Endocrinol Metab; 2012 Jul 01; 303(1):E122-31. PubMed ID: 22535748
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN.
    Dan Med J; 2015 Apr 01; 62(4):B5057. PubMed ID: 25872541
    [Abstract] [Full Text] [Related]

  • 3. GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects.
    Jiménez A, Casamitjana R, Flores L, Delgado S, Lacy A, Vidal J.
    Ann Surg; 2013 May 01; 257(5):894-9. PubMed ID: 23579541
    [Abstract] [Full Text] [Related]

  • 4. The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass.
    Kim MK, Lee HC, Lee SH, Kwon HS, Baek KH, Kim EK, Lee KW, Song KH.
    Diabetes Metab Res Rev; 2012 Jul 01; 28(5):439-46. PubMed ID: 22407971
    [Abstract] [Full Text] [Related]

  • 5. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M, Baldi S, Mari A, Colligiani D, Guarino D, Camastra S, Barsotti E, Berta R, Moriconi D, Bellini R, Anselmino M, Ferrannini E.
    J Clin Endocrinol Metab; 2013 Nov 01; 98(11):4391-9. PubMed ID: 24057293
    [Abstract] [Full Text] [Related]

  • 6. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.
    Clements RH, Gonzalez QH, Long CI, Wittert G, Laws HL.
    Am Surg; 2004 Jan 01; 70(1):1-4; discussion 4-5. PubMed ID: 14964537
    [Abstract] [Full Text] [Related]

  • 7. Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations.
    Jørgensen NB, Dirksen C, Bojsen-Møller KN, Kristiansen VB, Wulff BS, Rainteau D, Humbert L, Rehfeld JF, Holst JJ, Madsbad S, Clausen TR.
    J Clin Endocrinol Metab; 2015 Mar 01; 100(3):E396-406. PubMed ID: 25536209
    [Abstract] [Full Text] [Related]

  • 8. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
    Svane MS, Bojsen-Møller KN, Nielsen S, Jørgensen NB, Dirksen C, Bendtsen F, Kristiansen VB, Hartmann B, Holst JJ, Madsbad S.
    Am J Physiol Endocrinol Metab; 2016 Apr 01; 310(7):E505-14. PubMed ID: 26786780
    [Abstract] [Full Text] [Related]

  • 9. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
    Jacobsen SH, Olesen SC, Dirksen C, Jørgensen NB, Bojsen-Møller KN, Kielgast U, Worm D, Almdal T, Naver LS, Hvolris LE, Rehfeld JF, Wulff BS, Clausen TR, Hansen DL, Holst JJ, Madsbad S.
    Obes Surg; 2012 Jul 01; 22(7):1084-96. PubMed ID: 22359255
    [Abstract] [Full Text] [Related]

  • 10. Relevance of beta-cell function for improved glycemic control after gastric bypass surgery.
    Blanco J, Jiménez A, Casamitjana R, Flores L, Lacy A, Conget I, Vidal J.
    Surg Obes Relat Dis; 2014 Jul 01; 10(1):9-13; quiz 189-90. PubMed ID: 24342036
    [Abstract] [Full Text] [Related]

  • 11. Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery.
    Werling M, Vincent RP, Cross GF, Marschall HU, Fändriks L, Lönroth H, Taylor DR, Alaghband-Zadeh J, Olbers T, Le Roux CW.
    Scand J Gastroenterol; 2013 Nov 01; 48(11):1257-64. PubMed ID: 24044585
    [Abstract] [Full Text] [Related]

  • 12. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
    Pop LM, Mari A, Zhao TJ, Mitchell L, Burgess S, Li X, Adams-Huet B, Lingvay I.
    Diabetes Obes Metab; 2018 Jul 01; 20(7):1710-1721. PubMed ID: 29532631
    [Abstract] [Full Text] [Related]

  • 13. The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery.
    Patriti A, Facchiano E, Sanna A, Gullà N, Donini A.
    Obes Surg; 2004 Jul 01; 14(6):840-8. PubMed ID: 15318993
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Gastric bypass in the pig increases GIP levels and decreases active GLP-1 levels.
    Lindqvist A, Ekelund M, Pierzynowski S, Groop L, Hedenbro J, Wierup N.
    Peptides; 2017 Apr 01; 90():78-82. PubMed ID: 28242256
    [Abstract] [Full Text] [Related]

  • 16. Effects of transoral gastroplasty on glucose homeostasis in obese subjects.
    Leccesi L, Panunzi S, De Gaetano A, Familiari P, Iaconelli A, Guidone C, Mazzarella A, Costamagna G, Mingrone G.
    J Clin Endocrinol Metab; 2013 May 01; 98(5):1901-10. PubMed ID: 23543657
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of Manipulating Circulating Bile Acid Concentrations on Postprandial GLP-1 Secretion and Glucose Metabolism After Roux-en-Y Gastric Bypass.
    Jonsson I, Bojsen-Møller KN, Kristiansen VB, Veedfald S, Wewer Albrechtsen NJ, Clausen TR, Kuhre RE, Rehfeld JF, Holst JJ, Madsbad S, Svane MS.
    Front Endocrinol (Lausanne); 2021 May 01; 12():681116. PubMed ID: 34084153
    [Abstract] [Full Text] [Related]

  • 19. GK-rats respond to gastric bypass surgery with improved glycemia despite unaffected insulin secretion and beta cell mass.
    Miskelly MG, Shcherbina L, Thorén Fischer AH, Abels M, Lindqvist A, Wierup N.
    Peptides; 2021 Feb 01; 136():170445. PubMed ID: 33197511
    [Abstract] [Full Text] [Related]

  • 20. Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1.
    Speck M, Cho YM, Asadi A, Rubino F, Kieffer TJ.
    Am J Physiol Endocrinol Metab; 2011 May 01; 300(5):E923-32. PubMed ID: 21304061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.